an Economist Intelligence Unit business healthcare
Today our colleagues at NICE have published the latest Evidence Update, on Venous thromboembolism, jointly produced by NICE and Bazian. Evidence Updates "provide a regular, often annual, summary of selected new evidence published since the literature search was last conducted for the accredited guidance they update".
This Evidence Update includes selected evidence that has the potential to generate future change to the current NICE guidance Venous thromboembolism: reducing the risk (CG92), with commentaries appraising the new evidence and how it may impact on future practice. While the evidence identified as part of this Evidence Update was broadly confirmatory of current practice, it did highlight a number of evidence uncertainties, that have been added to the "Database about the Uncertainties of Effects of Treatments" (DUETs), which serves to highlight areas where further research is needed.
Bazian contributes to the Evidence Updates by scoping and undertaking systematic searches for new evidence published since the last searches were conducted for the baseline guideline. The evidence is then sifted and critically appraised by our Information Specialists, before being passed on to relevant subject area experts for their commentaries (the Evidence Update Advisory Group, no less).